CA
NZ
UK
AU
IND
US
Galaxy Digital Inc. filed a Current Report on Form 8-K with the SEC on August 5, 2026, disclosing its financial results for the quarter ended June 30, 2026, along with an accompanying press release, quarterly update presentation, and financial supplement.
SilverBox Corp IV filed a current report on August 5, 2026, disclosing that on August 4, 2026, the parties to its Business Combination Agreement with Parataxis Holdings LLC entered into a Second Amendment extending the Outside Date for completing the proposed business combination.
Criteo S.A. filed a Form 8-K on August 5, 2026, disclosing the appointment of Connor McGogney as Chief Financial Officer effective August 10, 2026, the planned departure of outgoing CFO Sarah Glickman, Q2 2026 financial results, and a share capital reduction following the cancellation …
FuboTV Inc. filed a Current Report on Form 8-K with the SEC on August 5, 2026, announcing its financial results for the quarter ended June 30, 2026, with the full details furnished via attached shareholder letter and press release.
Ivanhoe Electric Inc. filed a current report on August 5, 2026, disclosing an employment agreement with Michelle Lammers to serve as Chief Operating Officer, effective September 1, 2026, with compensation terms and severance provisions detailed under Item 5.02.
Advantage Solutions Inc. filed a Current Report on Form 8-K on August 5, 2026, disclosing the release of its financial results for the second quarter ended June 30, 2026, along with an accompanying earnings presentation and scheduled conference call.
Extreme Networks, Inc. filed a Current Report on Form 8-K with the SEC on August 5, 2026, announcing the availability of a press release covering certain financial results for its fourth quarter and fiscal year ended June 30, 2026.
Prologis, Inc. filed a Form 8-K on August 5, 2026, disclosing an underwritten public offering of 15,000,000 shares of common stock entered into on August 4, 2026, with net proceeds of approximately $2.1 billion expected to support general corporate purposes including a potential combination …
Summit Therapeutics Inc. filed a Form 8-K on August 5, 2026, announcing the planned initiation of the global Phase II/III HARMONi-GU1 trial, which will study ivonescimab in urothelial carcinoma.
News Corporation filed a Form 8-K on August 5, 2026, reporting that it provided Australian Securities Exchange daily repurchase disclosure documents as required under ASX rules, covering transactions under its existing $1 billion stock repurchase program.
Please wait processing your request...